156 related articles for article (PubMed ID: 29438178)
21. Surgery insight: surgical management of pancreatic cancer.
Michalski CW; Weitz J; Büchler MW
Nat Clin Pract Oncol; 2007 Sep; 4(9):526-35. PubMed ID: 17728711
[TBL] [Abstract][Full Text] [Related]
22. Utility of 18 fludeoxyglucose in preoperative positon-emission tomography-computed tomography (PET-CT) in the early diagnosis of exocrine pancreatic cancer: A study of 139 resected cases.
Sánchez-Bueno F; García-Pérez R; Claver Valderas MA; de la Peña Moral J; Frutos Esteban L; Ortiz Ruiz E; Fuster Quiñonero M; Parrilla Paricio P
Cir Esp; 2016 Nov; 94(9):511-517. PubMed ID: 27712835
[TBL] [Abstract][Full Text] [Related]
23. Two-staged treatment with local resection and percutaneous isolated hepatic chemoperfusion for advanced pancreatic cancer with multiple liver metastases: report of a case.
Suzuki Y; Ku Y; Tominaga M; Kamigaki T; Fujino Y; Tanioka Y; Iwasaki T; Fukumoto T; Takeyama Y; Kuroda Y
Hepatogastroenterology; 2001; 48(38):574-7. PubMed ID: 11379357
[TBL] [Abstract][Full Text] [Related]
24. SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer.
Pergolini I; Crippa S; Salgarello M; Belfiori G; Partelli S; Ruffo G; Pucci A; Zamboni G; Falconi M
Dig Liver Dis; 2018 Jan; 50(1):84-90. PubMed ID: 29017830
[TBL] [Abstract][Full Text] [Related]
25. Poorly differentiated ductal adenocarcinoma of the pancreas with rapid progression in a young man.
Tezuka K; Ishiyama T; Takeshita A; Matsumoto H; Jingu A; Kikuchi J; Yamaya H; Ohe R; Ishizawa T
Clin J Gastroenterol; 2018 Oct; 11(5):417-423. PubMed ID: 29663140
[TBL] [Abstract][Full Text] [Related]
26. [Pancreatic Cancer with Liver Metastasis Treated with Radical Surgery after Chemotherapy].
Katsura Y; Takeda Y; Ohmura Y; Sakamoto T; Inatome J; Naito A; Murakami K; Kagawa Y; Takeno A; Egawa C; Kato T; Tamura S
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1975-1977. PubMed ID: 28133194
[TBL] [Abstract][Full Text] [Related]
27. [Optimal duration and timing of adjuvant chemotherapy after resection for pancreatic ductal adenocarcinoma].
Strobel O; Büchler MW
Chirurg; 2014 Jun; 85(6):543. PubMed ID: 24824005
[No Abstract] [Full Text] [Related]
28. Stromal biology and therapy in pancreatic cancer: a changing paradigm.
Neesse A; Algül H; Tuveson DA; Gress TM
Gut; 2015 Sep; 64(9):1476-84. PubMed ID: 25994217
[TBL] [Abstract][Full Text] [Related]
29. Synchronic gastric and pancreatic ductal adenocarcinoma. A case report.
Santos-Fernández J; Arenal-Vera JJ; Cítores-Pascual MÁ; Fernández-Orcajo P; de-Benito-Sanz M; Benito-Fernández C; Tinoco-Carrasco C
Rev Esp Enferm Dig; 2015 Oct; 107(10):642-3. PubMed ID: 26437985
[TBL] [Abstract][Full Text] [Related]
30. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
31. Clinical Implications of Extensive Lymph Node Metastases for Resected Pancreatic Cancer.
Lowder CY; Metkus J; Epstein J; Kozak GM; Lavu H; Yeo CJ; Winter JM
Ann Surg Oncol; 2018 Dec; 25(13):4004-4011. PubMed ID: 30225835
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic carcinoma: Key-points from diagnosis to treatment.
Frampas E; David A; Regenet N; Touchefeu Y; Meyer J; Morla O
Diagn Interv Imaging; 2016 Dec; 97(12):1207-1223. PubMed ID: 27567314
[TBL] [Abstract][Full Text] [Related]
33. Current concepts in the surgical management of pancreatic cancer.
Thomas RM; Ahmad SA
Surg Oncol Clin N Am; 2010 Apr; 19(2):335-58. PubMed ID: 20159518
[TBL] [Abstract][Full Text] [Related]
34. Effects of the antioxidative vitamins A, C and E on liver metastasis and intrametastatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters.
Heukamp I; Kilian M; Gregor JI; Neumann A; Jacobi CA; Guski H; Schimke I; Walz MK; Wenger FA
Pancreatology; 2005; 5(4-5):403-9. PubMed ID: 15985764
[TBL] [Abstract][Full Text] [Related]
35. Slow growth of small pancreatic carcinoma with a 20-04 follow-up.
Shimada K; Onaya H; Esaki M; Sakamoto Y; Nara S; Kosuge T; Mizuguchi Y; Hiraoka N
Pancreas; 2009 Apr; 38(3):346-9. PubMed ID: 19307934
[No Abstract] [Full Text] [Related]
36. Successful outcome after resection of pancreatic cancer with a solitary hepatic metastasis.
Shimada K; Kosuge T; Yamamoto J; Yamasaki S; Sakamoto M
Hepatogastroenterology; 2004; 51(56):603-5. PubMed ID: 15086214
[TBL] [Abstract][Full Text] [Related]
37. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T
J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067
[TBL] [Abstract][Full Text] [Related]
38. Prognosis following surgical bypass compared with laparotomy alone in unresectable pancreatic adenocarcinoma.
Insulander J; Sanjeevi S; Haghighi M; Ivanics T; Analatos A; Lundell L; Del Chiaro M; Andrén-Sandberg Å; Ansorge C
Br J Surg; 2016 Aug; 103(9):1200-8. PubMed ID: 27250937
[TBL] [Abstract][Full Text] [Related]
39. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma.
Li W; Liu L; Liu D; Jin S; Yang Y; Tang W; Gong L
Biochem Biophys Res Commun; 2016 Mar; 472(1):156-62. PubMed ID: 26915801
[TBL] [Abstract][Full Text] [Related]
40. Clinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.
Chong JU; Hwang HK; Lee JH; Yun M; Kang CM; Lee WJ
PLoS One; 2017; 12(2):e0172606. PubMed ID: 28235029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
